0
ARTICLE |

Risk Factors for Cutaneous Melanoma: Title and subTitle BreakA Practical Method of Recognizing Predisposed Individuals FREE

Arthur R. Rhodes, MD, MPH; Martin A. Weinstock, MD, PhD; Thomas B. Fitzpatrick, MD, PhD; Martin C. Mihm, Jr, MD; Arthur J. Sober, MD
[+] Author Affiliations

Reprint requests to Department of Dermatology, Wellman 2, Massachusetts General Hospital, Boston, MA 02114 (Dr Rhodes).


JAMA. 1987;258(21):3146-3154. doi:10.1001/jama.1987.03400210088032
Text Size: A A A
Published online

Cutaneous melanoma is rapidly becoming a potentially curable cancer if it is detected and properly treated in an early phase of development. Unlike other cancers, which are usually hidden from detection until they are relatively large or metastatic disease has occurred, cutaneous melanoma is readily detectable simply by examining the skin. Information is now available that will be useful in selecting individuals at greatest risk. The most important melanoma risk factors (in decreasing order of importance) for a given individual are as follows: a persistently changed or changing mole, adulthood, irregular varieties of pigmented lesions (including dysplastic moles and lentigo maligna), a congenital mole, Caucasian race, a previous cutaneous melanoma, a family history of cutaneous melanoma, immunosuppression, sun sensitivity, and excessive sun exposure. Selective screening and appropriate treatment of individuals who have these risk factors may reduce the morbidity and mortality of cutaneous melanoma.

(JAMA 1987 258:3146-3154)

REFERENCES

Silverberg E, Lubera J:  Cancer statistics, 1987 . CA 1987;;37:2-19.
Horm JW, Asire AJ, Young JL Jr, et al: SEER Program: Cancer Incidence Mortality in the United States, 1973-1981 , US Dept of Health and Human Services publication (NIH) 85-1837. Bethesda, Md, National Cancer Institute, 1984;.
Vital Statistics of the United States, 1979 , US Dept of Health and Human Services publication (PHS) 84-1101. National Center for Health Statistics, 1984;, vol 2, pt A,  section 6 , p 8.
Roush GC, Schymura MJ, Holford TR:  Risk for cutaneous melanoma in recent Connecticut birth cohorts . Am J Public Health 1985;;75:679-682.
Balch CM, Soong S-J, Milton GW, et al:  Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia . Cancer 1983;;52:1748-1753.
Silverberg E:  Cancer statistics . CA 1983;;33:3-26.
Balch CM, Urist MM, Maddox WA, et al:  Melanoma in the Southern United States: Experience at the University of Alabama in Birmingham , in Balch CM, Milton GW, Shaw HM, et al (eds): Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide . Philadelphia, JB Lippincott, 1985;, pp 397-406.
Mihm MC Jr, Fitzpatrick TB, Lane-Brown MM, et al:  Early detection of primary cutaneous melanoma: A color atlas . N Engl J Med 1973;;289:989-996.
Sober AJ, Fitzpatrick TB, Mihm MC, et al:  Early recognition of cutaneous melanoma . JAMA 1979;;242:2795-2799.
Friedman RJ, Rigel DS, Kopf AW:  Early detection of malignant melanomas: The role of physician examination and self-examination of the skin . CA 1985;;35:130-151.
Elder DE, Greene MH, Bondi EE, et al:  Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome , in Ackerman AB (ed): Pathology of Malignant Melanoma . New York, Masson Publishers USA Inc, 1981;, pp 185-215.
Rhodes AR, Melski JW:  Small congenital nevocellular nevi and the risk of cutaneous melanoma . J Pediatr 1982;;100:219-224.
Doherty VR, MacKie RM:  Reasons for poor prognosis in British patients with cutaneous malignant melanoma . Br Med J 1986;;292:987-989.
Rhodes AR, Sober AJ, Mihm MC Jr, et al:  Possible risk factors for primary cutaneous malignant melanoma . Clin Res 1980;;28:252A.
Swerdlow AJ, English J, MacKie RM, et al:  Benign melanocytic nevi as a risk factor for malignant melanoma . Br Med J 1986;;292:1555-1559.
Rhodes AR:  Pigmented birthmarks and precursor melanocytic lesions of cutaneous melanoma identifiable in childhood . Pediatr Clin North Am 1983;;30:435-463.
Rhodes AR:  Melanocytic precursors of cutaneous melanoma: Estimated risks and guidelines for management . Med Clin North Am 1986;;70:3-37.
Rhodes AR:  Neoplasms: Benign neoplasias, hyperplasias, and dysplasias of melanocytes , in Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): Dermatology in General Medicine , ed 3. New York, McGraw-Hill International Book Co, 1986;, pp 877-946.
Sober AJ, Day CL, Kopf AW, et al:  Detection of'thin' primary melanomas . CA 1983;;33:160-163.
Wick MM, Sober AJ, Fitzpatrick TB, et al:  Clinical characteristics of early cutaneous melanoma . Cancer 1980;;45:2684-2686.
Houghton A, Flannery J, Viola MV:  Malignant melanoma in Connecticut and Denmark . Int J Cancer 1980;;25:95-104.
Preliminary Estimate of the Population of the United States by Age, Sex, and Race, 1970-1981 . Current Population Report Series P-25. US Bureau of Census, 1982;, p 10.
Bader JL, Li FP, Olmstead PM, et al:  Childhood malignant melanoma: Incidence and etiology . Am J Pediatr Hematol Oncol 1985;;7:341-345.
Rhodes AR, Melski JW, Sober AJ, et al:  Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma: A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines . J Invest Dermatol 1983;;80:452-459.
Greene MH, Clark WH Jr, Tucker MA, et al:  Acquired precursors of cutaneous malignant melanoma . N Engl J Med 1985;;312:91-97.
Kraemer KH, Greene MH:  Dysplastic nevi and cutaneous melanoma risk . Lancet 1983;;2:1076-1077.
Greene MH, Clark WH Jr, Tucker MA, et al:  The prospective diagnosis of malignant melanoma in a population at high risk: Hereditary melanoma and the dysplastic nevus syndrome . Ann Intern Med 1985;;102:458-465.
Rhodes AR, Harrist TJ, Day CL, et al:  Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas . J Am Acad Dermatol 1983;;9:563-574.
Clark WH Jr, Elder DE, Guerry DIV, et al:  A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma . Hum Pathol 1984;;15:1147-1165.
Bale SJ, Chakravarti A, Greene MH:  Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for autosomal dominance and pleiotropy . Am J Hum Genet 1986;;38:188-196.
Nordlund JJ, Kirkwood J, Forget BM, et al:  Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects . Cancer Res 1985;;45:1855-1861.
Kraemer KH, Tucker M, Tarone R, et al:  Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B . N Engl J Med 1986;;315:1615-1616.
Kraemer KH, Greene MH:  Dysplastic nevus syndrome: Familial and sporadic precursors of cutaneous melanoma . Dermatol Clin 1985;;3:225-237.
Crutcher WA, Sagebiel RW:  Prevalence of dysplastic nevi in a community practice . Lancet 1984;;1:729.
Swerdlow AJ, English J, MacKie RM, et al:  Benign naevi associated with high risk of melanoma . Lancet 1984;;2:168.
Reynolds P, Austin DF:  Epidemiologic-based screening strategies for malignant melanoma of the skin , in Engstrom PF, Anderson PN, Mortenson LE (eds): Advances in Cancer Control: Epidemiology and Research . New York, Alan R Liss Inc, 1984;, pp 245-254.
Green A, MacLennon R, Siskind V:  Common acquired nevi and the risk of malignant melanoma . Int J Cancer 1985;;35:297-300.
Holman CDJ, Armstrong BK:  Pigmentary traits, ethnic origin, benign nevi, and familial history as risk factors for cutaneous malignant melanoma . JNCI 1984;;72:257-266.
Elwood JM, Williamson C, Stapleton PJ:  Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources . Br JCancer 1986;;53:65-74.
Clark WH, Mihm MC:  Lentigo maligna and lentigo maligna melanoma . Am J Pathol 1969;;55:39-67.
Wayte DM, Helwig EB:  Melanotic freckle of Hutchinson . Cancer 1968;;21:893-911.
Weinstock MA, Sober AJ:  Risk of progression of lentigo maligna to lentigo maligna melanoma . Br J Dermatol 1987;;16:303-310.
Silvers DN:  Focus on melanoma: The therapeutic dilemma of lentigo maligna (Hutchinson's freckle) . J Dermatol Surg Oncol 1972;;2:301-302.
Walton RG, Jacobs AH, Cox AJ:  Pigmented lesions in newborn infants . Br J Dermatol 1976;;95:389-396.
Alper J, Holmes LB, Mihm MC:  Birthmarks with serious medical significance: Nevocellular nevi, sebaceous nevi, and multiple cafe-au-lait spots . J Pediatr 1979;;95:696-700.
Rhodes AR, Wood WC, Sober AJ, et al:  Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus . Plast Reconstr Surg 1981;;67:782-790.
Reed WB, Becker SW Sr, Becker SW Jr, et al:  Giant pigmented nevi, melanoma, and leptomeningeal melanocytosis: A clinical and histopathological study . Arch Dermatol 1965;;91:100-119.
Lanier V, Pickrell K, Georgiade NG:  Congenital giant nevi: Clinical and pathological considerations . Plast Reconstr Surg 1976;;58:48-54.
Trozak DJ, Rowland WD, Hu F:  Metastatic melanoma in prepubertal children . Pediatrics 1975;;55:191-204.
Pers M:  Naevus Pigmentosus Giganticus: Indikationer für Operativ Behandling . Ugeskr Laeger 1963;;125:613-620.
Lorentzen M, Pers M, Brettville-Jensen G:  The incidence of malignant transformation in giant pigmented nevi . Scand J Plast Reconstr Surg 1977;;11:163-167.
Rhodes AR, Sober AJ, Day CL, et al:  The malignant potential of small congenital nevocellular nevi: An estimate of association based on a histologic study of 234 primary cutaneous melanomas . J Am Acad Dermatol 1982;;60:230-241.
Illig L, Weidner F, Hundeiker M, et al:  Congenital nevi ≤ 10 cm as precursors to melanoma: 52 cases, a review, and a new conception . Arch Dermatol 1985;;121:1274-1281.
Elder DE:  The blind men and the elephant: Different views of small congenital nevi . Arch Dermatol 1985;;121:1263-1265.
 Precursors to malignant melanoma . JAMA 1984;;251:1864-1866.
Rhodes AR, Slifman NR, Korf BR:  Familial aggregation of small congenital nevomelanocytic nevi . Am J Med Genet 1985;;22:315-326.
Tucker MA, Boice JD, Hoffman DA:  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-1982 . NCI Monogr 1985;;68:161-189.
Veronesi U, Cascinelli N, Bufalino R:  Evaluation of the risk of multiple primaries in malignant cutaneous melanoma . Tumori 1976;;62:127-130.
Taylor MR, Guerry D IV, Bondi EE, et al:  Lack of association between intraocular melanoma and cutaneous dysplastic nevi . Am J Ophthalmol 1984;;98:478-482.
Duggleby WF, Stoll H, Priore RL, et al:  A genetic analysis of melanoma: Polygenetic inheritance as a threshold trait . Am J Epidemiol 1981;;114:63-72.
Greene MH, Young TI, Clark WH Jr:  Malignant melanoma in renal transplant recipients . Lancet 1981;;1:1196-1199.
Tucker MA, Misfeldt D, Coleman CN, et al:  Cutaneous malignant melanoma after Hodgkin's disease . Ann Intern Med 1985;;102:37-41.
Storm HH, Prener A:  Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-1980 . NCI Monogr 1985;;68:389-410.
Greene MH, Wilson J:  Second cancer following lymphatic and hematopoietic cancers in Connecticut 1935-1982 . NCI Monogr 1985;;68:191-217.
Green A, Siskind V, Bain C, et al:  Sunburn and malignant melanoma . Br J Cancer 1985;;51:393-397.
MacKie RM, Aitchinson T:  Severe sunburns and subsequent risk of primary cutaneous melanoma in Scotland . Br J Cancer 1982;;46:955-960.
Lew RA, Sober AJ, Cook N, et al:  Sun exposure habits in patients with cutaneous melanoma: A case control study . J Dermatol Surg Oncol 1983;;9:981-986.
Berel V, Evans S, Shaw H, et al:  Cutaneous factors related to the risk of malignant melanoma . Br J Dermatol 1983;;109:165-172.
Elwood JM, Gallagher RP, Davison J, et al:  Sunburn, suntan and the risk of cutaneous malignant melanoma: The Western Canada Melanoma Study . Br J Cancer 1985;;51:543-549.
Green A, Bain C, McLennan R, et al:  Risk factors for cutaneous melanoma in Queensland . Recent Results Cancer Res 1986;;102:76-97.
Green A:  Sun exposure and the risk of melanoma . Aust J Dermatol 1984;;25:99-102.
Holman CDJ, Armstrong BK, Heenan PJ:  Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits . JNCI 1986;;76:403-414.
Graham S, Marshall J, Haughey B, et al:  An inquiry into the epidemiology of melanoma . Am J Epidemiol 1985;;122:606-619.
Dobson AJ, Leeder SR:  Mortality from malignant melanoma in Australia: Effects due to country of birth . Int JEpidemiol 1982;;11:207-211.
Rampen FHJ, Van Der Meeren HLM, Boezeman JBM:  Frequency of moles as a key to melanoma incidence . J Am Acad Dermatol 1986;;15:1200-1203.
English JSC, Swerdlow AJ, MacKie RM, et al:  Relation between phenotype and banal melanocytic naevi . Br Med J 1987;;294:152-154.
Holman CDJ, Armstrong BK:  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenic types . JNCI 1984;;73:75-82.
Cooke KR, Fraser J:  Migration and death from malignant melanoma . Int J Cancer 1985;;36:175-178.
Elwood JM, Lee JAH:  Recent data on the epidemiology of malignant melanoma . Semin Oncol 1975;;2:149-154.
Magnus K:  Habits of sun exposure and risk of malignant melanoma . Cancer 1981;;48:2329-2335.
Lee LAH:  Melanoma and exposure to sunlight . Epidemiol Rev 1982;;4:110-136.
Elwood JM, Gallagher RP, Hill GB, et al:  Cutaneous melanoma in relation to intermittent and constant sun exposure: The Western Canada Melanoma Study . Int J Cancer 1985;;35:427-433.
Anaise D, Steinitz R, Ben Hur N:  Solar radiation: A possible etiologic factor in malignant melanoma in Israel . Cancer 1978;;42:299-304.
Kopf AW, Lazar M, Bart RS, et al:  Prevalence of nevocytic nevi on lateral and medial aspects of arms . J Dermatol Surg Oncol 1978;;4:153-158.
Kopf AW, Lindsay AC, Rogers GS, et al:  Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndrome . J Am Acad Dermatol 1985;;12:656-662.
Roush GC, Barnhill RL, Duray PH, et al:  Diagnosis of the dysplastic nevus in different populations . J Am Acad Dermatol 1987;;14:419-425.
Kripke ML:  Speculations on the role of ultraviolet radiation in the development of malignant melanoma . JNCI 1979;;63:541-545.
Robbins JH, Moshell AN:  DNA repair processes protect human beings from premature solar skin damage: Evidence from studies on xeroderma pigmentosum . J Invest Dermatol 1979;;73:102-107.
Rhodes AR:  Melanocytic precursors of cutaneous melanoma , in Fitzpatrick TB, Wick MM, Toda K (eds): Brown Melanoderma: Biology and Diseases of Epidermal Pigmentation . Tokyo, University of Tokyo Press, 1986;, pp 129-147.
Anders F, Schartl M, Barnekow A, et al:  The genes that carcinogens act upon . Haematol Blood Trans 1985;;29:228-252.
Howell JN, Greene MH, Corner RC, et al:  Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide . Proc Natl Acad Sci USA 1984;;81:1179-1183.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Silverberg E, Lubera J:  Cancer statistics, 1987 . CA 1987;;37:2-19.
Horm JW, Asire AJ, Young JL Jr, et al: SEER Program: Cancer Incidence Mortality in the United States, 1973-1981 , US Dept of Health and Human Services publication (NIH) 85-1837. Bethesda, Md, National Cancer Institute, 1984;.
Vital Statistics of the United States, 1979 , US Dept of Health and Human Services publication (PHS) 84-1101. National Center for Health Statistics, 1984;, vol 2, pt A,  section 6 , p 8.
Roush GC, Schymura MJ, Holford TR:  Risk for cutaneous melanoma in recent Connecticut birth cohorts . Am J Public Health 1985;;75:679-682.
Balch CM, Soong S-J, Milton GW, et al:  Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia . Cancer 1983;;52:1748-1753.
Silverberg E:  Cancer statistics . CA 1983;;33:3-26.
Balch CM, Urist MM, Maddox WA, et al:  Melanoma in the Southern United States: Experience at the University of Alabama in Birmingham , in Balch CM, Milton GW, Shaw HM, et al (eds): Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide . Philadelphia, JB Lippincott, 1985;, pp 397-406.
Mihm MC Jr, Fitzpatrick TB, Lane-Brown MM, et al:  Early detection of primary cutaneous melanoma: A color atlas . N Engl J Med 1973;;289:989-996.
Sober AJ, Fitzpatrick TB, Mihm MC, et al:  Early recognition of cutaneous melanoma . JAMA 1979;;242:2795-2799.
Friedman RJ, Rigel DS, Kopf AW:  Early detection of malignant melanomas: The role of physician examination and self-examination of the skin . CA 1985;;35:130-151.
Elder DE, Greene MH, Bondi EE, et al:  Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome , in Ackerman AB (ed): Pathology of Malignant Melanoma . New York, Masson Publishers USA Inc, 1981;, pp 185-215.
Rhodes AR, Melski JW:  Small congenital nevocellular nevi and the risk of cutaneous melanoma . J Pediatr 1982;;100:219-224.
Doherty VR, MacKie RM:  Reasons for poor prognosis in British patients with cutaneous malignant melanoma . Br Med J 1986;;292:987-989.
Rhodes AR, Sober AJ, Mihm MC Jr, et al:  Possible risk factors for primary cutaneous malignant melanoma . Clin Res 1980;;28:252A.
Swerdlow AJ, English J, MacKie RM, et al:  Benign melanocytic nevi as a risk factor for malignant melanoma . Br Med J 1986;;292:1555-1559.
Rhodes AR:  Pigmented birthmarks and precursor melanocytic lesions of cutaneous melanoma identifiable in childhood . Pediatr Clin North Am 1983;;30:435-463.
Rhodes AR:  Melanocytic precursors of cutaneous melanoma: Estimated risks and guidelines for management . Med Clin North Am 1986;;70:3-37.
Rhodes AR:  Neoplasms: Benign neoplasias, hyperplasias, and dysplasias of melanocytes , in Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): Dermatology in General Medicine , ed 3. New York, McGraw-Hill International Book Co, 1986;, pp 877-946.
Sober AJ, Day CL, Kopf AW, et al:  Detection of'thin' primary melanomas . CA 1983;;33:160-163.
Wick MM, Sober AJ, Fitzpatrick TB, et al:  Clinical characteristics of early cutaneous melanoma . Cancer 1980;;45:2684-2686.
Houghton A, Flannery J, Viola MV:  Malignant melanoma in Connecticut and Denmark . Int J Cancer 1980;;25:95-104.
Preliminary Estimate of the Population of the United States by Age, Sex, and Race, 1970-1981 . Current Population Report Series P-25. US Bureau of Census, 1982;, p 10.
Bader JL, Li FP, Olmstead PM, et al:  Childhood malignant melanoma: Incidence and etiology . Am J Pediatr Hematol Oncol 1985;;7:341-345.
Rhodes AR, Melski JW, Sober AJ, et al:  Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma: A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines . J Invest Dermatol 1983;;80:452-459.
Greene MH, Clark WH Jr, Tucker MA, et al:  Acquired precursors of cutaneous malignant melanoma . N Engl J Med 1985;;312:91-97.
Kraemer KH, Greene MH:  Dysplastic nevi and cutaneous melanoma risk . Lancet 1983;;2:1076-1077.
Greene MH, Clark WH Jr, Tucker MA, et al:  The prospective diagnosis of malignant melanoma in a population at high risk: Hereditary melanoma and the dysplastic nevus syndrome . Ann Intern Med 1985;;102:458-465.
Rhodes AR, Harrist TJ, Day CL, et al:  Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas . J Am Acad Dermatol 1983;;9:563-574.
Clark WH Jr, Elder DE, Guerry DIV, et al:  A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma . Hum Pathol 1984;;15:1147-1165.
Bale SJ, Chakravarti A, Greene MH:  Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for autosomal dominance and pleiotropy . Am J Hum Genet 1986;;38:188-196.
Nordlund JJ, Kirkwood J, Forget BM, et al:  Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects . Cancer Res 1985;;45:1855-1861.
Kraemer KH, Tucker M, Tarone R, et al:  Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B . N Engl J Med 1986;;315:1615-1616.
Kraemer KH, Greene MH:  Dysplastic nevus syndrome: Familial and sporadic precursors of cutaneous melanoma . Dermatol Clin 1985;;3:225-237.
Crutcher WA, Sagebiel RW:  Prevalence of dysplastic nevi in a community practice . Lancet 1984;;1:729.
Swerdlow AJ, English J, MacKie RM, et al:  Benign naevi associated with high risk of melanoma . Lancet 1984;;2:168.
Reynolds P, Austin DF:  Epidemiologic-based screening strategies for malignant melanoma of the skin , in Engstrom PF, Anderson PN, Mortenson LE (eds): Advances in Cancer Control: Epidemiology and Research . New York, Alan R Liss Inc, 1984;, pp 245-254.
Green A, MacLennon R, Siskind V:  Common acquired nevi and the risk of malignant melanoma . Int J Cancer 1985;;35:297-300.
Holman CDJ, Armstrong BK:  Pigmentary traits, ethnic origin, benign nevi, and familial history as risk factors for cutaneous malignant melanoma . JNCI 1984;;72:257-266.
Elwood JM, Williamson C, Stapleton PJ:  Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources . Br JCancer 1986;;53:65-74.
Clark WH, Mihm MC:  Lentigo maligna and lentigo maligna melanoma . Am J Pathol 1969;;55:39-67.
Wayte DM, Helwig EB:  Melanotic freckle of Hutchinson . Cancer 1968;;21:893-911.
Weinstock MA, Sober AJ:  Risk of progression of lentigo maligna to lentigo maligna melanoma . Br J Dermatol 1987;;16:303-310.
Silvers DN:  Focus on melanoma: The therapeutic dilemma of lentigo maligna (Hutchinson's freckle) . J Dermatol Surg Oncol 1972;;2:301-302.
Walton RG, Jacobs AH, Cox AJ:  Pigmented lesions in newborn infants . Br J Dermatol 1976;;95:389-396.
Alper J, Holmes LB, Mihm MC:  Birthmarks with serious medical significance: Nevocellular nevi, sebaceous nevi, and multiple cafe-au-lait spots . J Pediatr 1979;;95:696-700.
Rhodes AR, Wood WC, Sober AJ, et al:  Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus . Plast Reconstr Surg 1981;;67:782-790.
Reed WB, Becker SW Sr, Becker SW Jr, et al:  Giant pigmented nevi, melanoma, and leptomeningeal melanocytosis: A clinical and histopathological study . Arch Dermatol 1965;;91:100-119.
Lanier V, Pickrell K, Georgiade NG:  Congenital giant nevi: Clinical and pathological considerations . Plast Reconstr Surg 1976;;58:48-54.
Trozak DJ, Rowland WD, Hu F:  Metastatic melanoma in prepubertal children . Pediatrics 1975;;55:191-204.
Pers M:  Naevus Pigmentosus Giganticus: Indikationer für Operativ Behandling . Ugeskr Laeger 1963;;125:613-620.
Lorentzen M, Pers M, Brettville-Jensen G:  The incidence of malignant transformation in giant pigmented nevi . Scand J Plast Reconstr Surg 1977;;11:163-167.
Rhodes AR, Sober AJ, Day CL, et al:  The malignant potential of small congenital nevocellular nevi: An estimate of association based on a histologic study of 234 primary cutaneous melanomas . J Am Acad Dermatol 1982;;60:230-241.
Illig L, Weidner F, Hundeiker M, et al:  Congenital nevi ≤ 10 cm as precursors to melanoma: 52 cases, a review, and a new conception . Arch Dermatol 1985;;121:1274-1281.
Elder DE:  The blind men and the elephant: Different views of small congenital nevi . Arch Dermatol 1985;;121:1263-1265.
 Precursors to malignant melanoma . JAMA 1984;;251:1864-1866.
Rhodes AR, Slifman NR, Korf BR:  Familial aggregation of small congenital nevomelanocytic nevi . Am J Med Genet 1985;;22:315-326.
Tucker MA, Boice JD, Hoffman DA:  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-1982 . NCI Monogr 1985;;68:161-189.
Veronesi U, Cascinelli N, Bufalino R:  Evaluation of the risk of multiple primaries in malignant cutaneous melanoma . Tumori 1976;;62:127-130.
Taylor MR, Guerry D IV, Bondi EE, et al:  Lack of association between intraocular melanoma and cutaneous dysplastic nevi . Am J Ophthalmol 1984;;98:478-482.
Duggleby WF, Stoll H, Priore RL, et al:  A genetic analysis of melanoma: Polygenetic inheritance as a threshold trait . Am J Epidemiol 1981;;114:63-72.
Greene MH, Young TI, Clark WH Jr:  Malignant melanoma in renal transplant recipients . Lancet 1981;;1:1196-1199.
Tucker MA, Misfeldt D, Coleman CN, et al:  Cutaneous malignant melanoma after Hodgkin's disease . Ann Intern Med 1985;;102:37-41.
Storm HH, Prener A:  Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-1980 . NCI Monogr 1985;;68:389-410.
Greene MH, Wilson J:  Second cancer following lymphatic and hematopoietic cancers in Connecticut 1935-1982 . NCI Monogr 1985;;68:191-217.
Green A, Siskind V, Bain C, et al:  Sunburn and malignant melanoma . Br J Cancer 1985;;51:393-397.
MacKie RM, Aitchinson T:  Severe sunburns and subsequent risk of primary cutaneous melanoma in Scotland . Br J Cancer 1982;;46:955-960.
Lew RA, Sober AJ, Cook N, et al:  Sun exposure habits in patients with cutaneous melanoma: A case control study . J Dermatol Surg Oncol 1983;;9:981-986.
Berel V, Evans S, Shaw H, et al:  Cutaneous factors related to the risk of malignant melanoma . Br J Dermatol 1983;;109:165-172.
Elwood JM, Gallagher RP, Davison J, et al:  Sunburn, suntan and the risk of cutaneous malignant melanoma: The Western Canada Melanoma Study . Br J Cancer 1985;;51:543-549.
Green A, Bain C, McLennan R, et al:  Risk factors for cutaneous melanoma in Queensland . Recent Results Cancer Res 1986;;102:76-97.
Green A:  Sun exposure and the risk of melanoma . Aust J Dermatol 1984;;25:99-102.
Holman CDJ, Armstrong BK, Heenan PJ:  Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits . JNCI 1986;;76:403-414.
Graham S, Marshall J, Haughey B, et al:  An inquiry into the epidemiology of melanoma . Am J Epidemiol 1985;;122:606-619.
Dobson AJ, Leeder SR:  Mortality from malignant melanoma in Australia: Effects due to country of birth . Int JEpidemiol 1982;;11:207-211.
Rampen FHJ, Van Der Meeren HLM, Boezeman JBM:  Frequency of moles as a key to melanoma incidence . J Am Acad Dermatol 1986;;15:1200-1203.
English JSC, Swerdlow AJ, MacKie RM, et al:  Relation between phenotype and banal melanocytic naevi . Br Med J 1987;;294:152-154.
Holman CDJ, Armstrong BK:  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenic types . JNCI 1984;;73:75-82.
Cooke KR, Fraser J:  Migration and death from malignant melanoma . Int J Cancer 1985;;36:175-178.
Elwood JM, Lee JAH:  Recent data on the epidemiology of malignant melanoma . Semin Oncol 1975;;2:149-154.
Magnus K:  Habits of sun exposure and risk of malignant melanoma . Cancer 1981;;48:2329-2335.
Lee LAH:  Melanoma and exposure to sunlight . Epidemiol Rev 1982;;4:110-136.
Elwood JM, Gallagher RP, Hill GB, et al:  Cutaneous melanoma in relation to intermittent and constant sun exposure: The Western Canada Melanoma Study . Int J Cancer 1985;;35:427-433.
Anaise D, Steinitz R, Ben Hur N:  Solar radiation: A possible etiologic factor in malignant melanoma in Israel . Cancer 1978;;42:299-304.
Kopf AW, Lazar M, Bart RS, et al:  Prevalence of nevocytic nevi on lateral and medial aspects of arms . J Dermatol Surg Oncol 1978;;4:153-158.
Kopf AW, Lindsay AC, Rogers GS, et al:  Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndrome . J Am Acad Dermatol 1985;;12:656-662.
Roush GC, Barnhill RL, Duray PH, et al:  Diagnosis of the dysplastic nevus in different populations . J Am Acad Dermatol 1987;;14:419-425.
Kripke ML:  Speculations on the role of ultraviolet radiation in the development of malignant melanoma . JNCI 1979;;63:541-545.
Robbins JH, Moshell AN:  DNA repair processes protect human beings from premature solar skin damage: Evidence from studies on xeroderma pigmentosum . J Invest Dermatol 1979;;73:102-107.
Rhodes AR:  Melanocytic precursors of cutaneous melanoma , in Fitzpatrick TB, Wick MM, Toda K (eds): Brown Melanoderma: Biology and Diseases of Epidermal Pigmentation . Tokyo, University of Tokyo Press, 1986;, pp 129-147.
Anders F, Schartl M, Barnekow A, et al:  The genes that carcinogens act upon . Haematol Blood Trans 1985;;29:228-252.
Howell JN, Greene MH, Corner RC, et al:  Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide . Proc Natl Acad Sci USA 1984;;81:1179-1183.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.